Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Rinaldi

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|April 6, 2011
Percutaneous repair or surgery for mitral regurgitationTed Feldman, Elyse Foster, Donald D Glower, et al.
American Heart Journal|September 10, 2018
Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stentsChristine J Chung, Ajay J Kirtane, Yiran Zhang, et al.
Circulation|November 28, 2013
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) studyBernhard Witzenbichler, Akiko Maehara, Giora Weisz, et al.
Circulation. Cardiovascular Interventions|December 9, 2015
Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES StudyTomotaka Dohi, Akiko Maehara, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention PopulationSorin J Brener, Ajay J Kirtane, Michael J Rinaldi, et al.
Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|July 1, 2019
Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP StudyD Scott Lim, Saibal Kar, Konstantinos Spargias, et al.
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|April 6, 2011
Percutaneous repair or surgery for mitral regurgitationTed Feldman, Elyse Foster, Donald D Glower, et al.
American Heart Journal|September 10, 2018
Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stentsChristine J Chung, Ajay J Kirtane, Yiran Zhang, et al.
Circulation|November 28, 2013
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) studyBernhard Witzenbichler, Akiko Maehara, Giora Weisz, et al.
Circulation. Cardiovascular Interventions|December 9, 2015
Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES StudyTomotaka Dohi, Akiko Maehara, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention PopulationSorin J Brener, Ajay J Kirtane, Michael J Rinaldi, et al.
Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|July 1, 2019
Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP StudyD Scott Lim, Saibal Kar, Konstantinos Spargias, et al.
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
Pageof 8